MS research

Oligodendrocytes, the cells that build and repair myelin in the brain and spinal cord, may play a role in the inflammatory processes involved in multiple sclerosis (MS), even at the earliest stages of disease, according to a study in a mouse model. “We found that oligodendrocytes transition to disease…

Scientists at Case Western Reserve University (CWRU) in Ohio will use a new $2.5 million donation from the Thomas F. Peterson Jr. Charitable Trust to develop therapeutic strategies for multiple sclerosis (MS) and other neurological diseases. The commitment will support Paul Tesar, PhD, a CWRU professor and director of the…

Denise Schnieders is a wife, mom, teacher, volleyball coach, and passionate advocate living with multiple sclerosis (MS). Since her diagnosis, she’s become a powerful voice in the MS community, raising awareness, advocating for better healthcare policy, and pushing for more research funding. Through her platform, MSdopaminedressed, Schnieders shares…

A pair of scientists have been awarded a 2025 Breakthrough Prize in Life Sciences for their work uncovering factors that give rise to multiple sclerosis (MS), paving the way for new therapeutic developments. Sometimes referred to as the “Oscars of Science,” Breakthrough Prizes are given each year to…

A researcher and neurologist at Penn Medicine in Philadelphia has won the 2025 John Dystel Prize for Multiple Sclerosis Research for his work in uncovering immune mechanisms of multiple sclerosis (MS), identifying disease biomarkers, and finding new avenues toward tailored medicine. The prize comes with a sculpture and…

Mikael Simons, MD, a neurologist at Technical University Munich, has been awarded this year’s $125,000 Barancik Prize for his extensive research on myelin, a protective coating that sheathes nerve cells and becomes damaged in multiple sclerosis (MS). Run by the National MS Society and funded by the Charles…

Tech company Century Health has entered into a partnership to organize and clean Nira Medical‘s datasets from more than 3,000 people with multiple sclerosis (MS) to help make clinical data more available for researchers to explore insights toward developing new treatments. “We’re thrilled to partner with Nira…

Blood levels of neurofilament light chain (NfL) — a biomarker of nerve cell damage used in multiple sclerosis (MS) research — are influenced by factors such as age, body mass index (BMI), and storage conditions of the blood samples, according to a recent report. Such factors may need to…

The National Multiple Sclerosis Society is awarding a total of $4.6 million in funding to advance research into how the protective myelin sheath that’s damaged in multiple sclerosis (MS) can be repaired — a step toward developing new treatments for the disease. Five research projects have been chosen…

A PhD student at the UMass Chan Medical School will use funding from a newly awarded fellowship to advance his research into the mechanisms used by cells to repair myelin, the protective sheath around nerve cells that’s damaged in multiple sclerosis (MS) and other demyelinating conditions. The ongoing…

Alexander Gow, PhD, a professor at Wayne State University School of Medicine in Detroit, has been awarded a grant to study how stressed oligodendrocytes, the cells that produce myelin in the brain and spinal cord, could be at the origin of multiple sclerosis (MS). The three-year, $644,827 grant from…

Metabolon and Cardiff University are partnering to discover new biomarkers that could help better understand disease mechanisms and develop new treatments for multiple sclerosis (MS). The project leverages Metabolon’s expertise in metabolomics, a field of research that measures all products of metabolism, called metabolites, that are made…

Scientists have developed a technique to more precisely map the myelin sheath, the fatty covering around nerve fibers that is damaged in multiple sclerosis (MS), in people undergoing an imaging scan. While further work is needed, its use “produced promising initial results,” the scientists wrote, noting that this…

Junctions between nerve cells and certain cells called oligodendrocyte precursor cells, or OPCs, in the brain and spinal cord may play an important role in producing myelin, the protective substance that’s progressively lost in multiple sclerosis (MS), new research suggests. OPCs are abundant in the brain and spinal…

The European Union (EU) is providing 7.1 million euros (about $7.6 million) over five years to a global interdisciplinary consortium that seeks to identify the causes of multiple sclerosis (MS) — with a particular focus on viruses — and find new treatments for the disease. The “BEHIND MS”…

A day of golfing is in store for those who want to support Johns Hopkins Hospital’s efforts on behalf of research for multiple sclerosis (MS) and to raise awareness about the progressive neurodegenerative disorder. The #spreadingORANGE event will aid the Johns Hopkins Multiple Sclerosis Center along with MS…

To address knowledge gaps and avoid duplicate efforts in the lab and in trials, 10 multiple sclerosis (MS) organizations from around the world have committed to a single global research strategy to find a cure for the progressive neurodegenerative disorder. The nonprofits, with headquarters in countries ranging from the…

University of Manitoba neurologist and investigator Ruth Ann Marrie has won the National Multiple Sclerosis Society‘s (NMSS) Barancik Prize for Innovation in MS Research for her landmark discoveries in multiple sclerosis (MS). Now in its 10th year, the prize recognizes and promotes innovation and originality in MS-related…

With a goal of better treatment and care for people with multiple sclerosis (MS), Verana Health is developing a neurology module for disease research that includes de-identified and curated real-world data covering more than 30,000 MS patients. The digital health company is developing Qdata MS to…

Innovative Trials has selected the MS Society UK as its charity partner for the next year, and intends to raise at least £3,000 (about $3,600) to support multiple sclerosis (MS) research and the society’s quest for a world without MS. Innovative Trials works with pharmaceutical companies and…

Living with multiple sclerosis (MS) is hard. I know this is hardly a revelation, especially to those of us who struggle with it on the daily, but I felt like it needed to be said. I was scanning through articles on this site recently, seeing what my fellow…

I always knew that living with multiple sclerosis (MS) was super-expensive, but a new study is a real eye-opener. The study, published in the journal Neurology, puts the annual tab for MS in…

The MS Society of Canada is providing thousands in funding to 66 research projects that aim to accelerate scientific understand of multiple sclerosis (MS) and to improve care for people with the disease. The society announced the winners of its 2022–23 Annual Research Competition in four categories…

The dull throbbing always hits a crescendo “in the wee small hours,” as Mr. Sinatra — or rather his songwriters — so aptly put it. I’m referring to a wound that’s been with me for over a year now. True, it disappeared for a teeny while, when my heel…

The MS Society of the U.K. intends to raise over £1.1 million (about $1.5 million) to support nine multiple sclerosis (MS) research projects, marking the return of the grants program it put on hold due to the COVID-19 pandemic. Funding will support research in the…

My immediate thought after reading a recent MS News Today headline stating that trigeminal neuralgia (TN) affects more than 3% of MS patients was, “Really, only 3%?” The reason is I’ve seen several complaints about the condition, which causes excruciating pain in the face. As the story noted, TN…

I’ve been popping vitamin D pills for years — decades, really. I never really understood why, I just knew that many people with multiple sclerosis (MS) are vitamin D-deficient. A recent study has cast some new light on why I should continue. It all seems to comes down to…

The National Multiple Sclerosis Society invested more than $8.7 million over the summer to support 29 new training fellowships, early career research awards, and other initiatives aiming to advance multiple sclerosis (MS) research and care. Awarded research projects align with the society’s Pathways to Cures Roadmap: stopping disease activity and…

A nurse and PhD candidate with multiple sclerosis (MS) is looking for disease biomarkers that can help healthcare providers better estimate how individual cases of MS will progress. The goal of Stephanie Buxhoeveden’s research, now supported by a grant from the American Association of Nurse Practitioners (AANP), is…

Alan Thompson, dean of the Faculty of Brain Sciences at University College London (UCL), has won the 2021 Charcot Award, a prize given once every two years for a lifetime of achievement in research into the understanding and treatment of multiple sclerosis (MS). “The Charcot Award is viewed by…